NZ596722A - A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof - Google Patents

A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof

Info

Publication number
NZ596722A
NZ596722A NZ596722A NZ59672210A NZ596722A NZ 596722 A NZ596722 A NZ 596722A NZ 596722 A NZ596722 A NZ 596722A NZ 59672210 A NZ59672210 A NZ 59672210A NZ 596722 A NZ596722 A NZ 596722A
Authority
NZ
New Zealand
Prior art keywords
temperature sensitive
mycoplasma hyopneumoniae
vaccine strain
sensitive vaccine
strain
Prior art date
Application number
NZ596722A
Other languages
English (en)
Inventor
Rima Youil
El-Osta Youssef Abs
Phillip Markham
Glenn Browning
Original Assignee
Univ Melbourne
Bioproperties Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009902255A external-priority patent/AU2009902255A0/en
Application filed by Univ Melbourne, Bioproperties Pty Ltd filed Critical Univ Melbourne
Publication of NZ596722A publication Critical patent/NZ596722A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
NZ596722A 2009-05-19 2010-05-19 A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof NZ596722A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009902255A AU2009902255A0 (en) 2009-05-19 Bacterial strain, vaccine and uses thereof
PCT/AU2010/000590 WO2010132932A1 (en) 2009-05-19 2010-05-19 A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof

Publications (1)

Publication Number Publication Date
NZ596722A true NZ596722A (en) 2013-08-30

Family

ID=43125658

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ596722A NZ596722A (en) 2009-05-19 2010-05-19 A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof

Country Status (17)

Country Link
US (1) US8524252B2 (cg-RX-API-DMAC7.html)
EP (1) EP2453913B1 (cg-RX-API-DMAC7.html)
JP (1) JP5744852B2 (cg-RX-API-DMAC7.html)
KR (1) KR101734590B1 (cg-RX-API-DMAC7.html)
CN (1) CN102458462B (cg-RX-API-DMAC7.html)
AU (1) AU2010251761B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI1010679B1 (cg-RX-API-DMAC7.html)
CA (1) CA2762587C (cg-RX-API-DMAC7.html)
CL (1) CL2011002923A1 (cg-RX-API-DMAC7.html)
DK (1) DK2453913T3 (cg-RX-API-DMAC7.html)
EA (1) EA021102B1 (cg-RX-API-DMAC7.html)
ES (1) ES2579935T3 (cg-RX-API-DMAC7.html)
MX (1) MX2011012362A (cg-RX-API-DMAC7.html)
NZ (1) NZ596722A (cg-RX-API-DMAC7.html)
PE (1) PE20120909A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010132932A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201109185B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012013409A (es) * 2010-05-19 2013-03-07 Bioproperties Pty Ltd Metodos relacionados a un micoplasma atenuado.
CN104685057B (zh) * 2012-07-10 2019-04-16 海博莱科学有限公司 用于转化猪肺炎支原体的载体,转化的猪肺炎支原体菌株及其用途
EP2684959A1 (en) 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
AU2013370982C9 (en) 2012-12-28 2019-01-24 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition comprising mycoplasma antigens
EP2913947B1 (en) * 2014-02-27 2019-11-27 ADVA Optical Networking SE Passive optical network and optical line terminal
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
AU2016380864B2 (en) 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof
US10071149B2 (en) 2016-05-03 2018-09-11 Brigham Young University Temperature sensitive multivalent Bordetella avium vaccines
CN113278575B (zh) * 2021-07-13 2021-12-31 南华大学 一种肺炎支原体减毒突变株及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
CN1100871C (zh) * 1999-06-25 2003-02-05 江苏省农业科学院畜牧兽医研究所 猪肺炎支原体克隆致弱株
US6673567B2 (en) * 2000-03-23 2004-01-06 E. I. Du Pont De Nemours And Company Method of determination of gene function
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
MXPA03011924A (es) * 2001-07-02 2004-03-26 Pfizer Prod Inc Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
JP2009528361A (ja) * 2006-03-03 2009-08-06 メリアル リミテッド マイコプラズマ・ハイオニューモニエワクチン
US9056909B2 (en) * 2007-11-06 2015-06-16 Zoetis Services Llc Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
DK2475384T3 (en) * 2009-09-10 2016-10-24 Merial Inc NEW VACCINE FORMULATIONS COMPREHENSIVE saponin-CONTAINING ADJUVANTS
US9324223B2 (en) 2012-06-08 2016-04-26 3M Innovative Properties Company Electronic monitoring home unit and installation methods

Also Published As

Publication number Publication date
KR20120016282A (ko) 2012-02-23
EP2453913B1 (en) 2016-06-22
EP2453913A1 (en) 2012-05-23
EP2453913A4 (en) 2013-10-30
CN102458462B (zh) 2014-03-19
US20120135040A1 (en) 2012-05-31
WO2010132932A1 (en) 2010-11-25
AU2010251761A1 (en) 2011-12-22
CN102458462A (zh) 2012-05-16
PE20120909A1 (es) 2012-08-19
EA201190311A1 (ru) 2012-06-29
DK2453913T3 (en) 2016-07-25
JP5744852B2 (ja) 2015-07-08
ZA201109185B (en) 2012-09-26
BRPI1010679B1 (pt) 2020-09-24
CL2011002923A1 (es) 2012-08-31
MX2011012362A (es) 2012-04-19
EA021102B1 (ru) 2015-04-30
CA2762587C (en) 2017-11-28
CA2762587A1 (en) 2010-11-25
JP2012527218A (ja) 2012-11-08
KR101734590B1 (ko) 2017-05-11
ES2579935T3 (es) 2016-08-17
AU2010251761B2 (en) 2014-10-09
BRPI1010679A2 (pt) 2017-07-18
US8524252B2 (en) 2013-09-03

Similar Documents

Publication Publication Date Title
MX2011012362A (es) Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma.
NZ589251A (en) Novel marker for detection of bladder cancer
UA105821C2 (uk) Візирний пристрій
WO2011052996A3 (en) Novel lactobacillus plantarum and composition comprising the same
SA113340703B1 (ar) سلالة جديدة من بكتيريا Lactobacillus Crispatus
IN2015KN00364A (cg-RX-API-DMAC7.html)
EA201201608A1 (ru) Солнцезащитная композиция
SA515360414B1 (ar) صلب من النوعية ذات درجة الحرارة العالية لمعدات مفاعل ذي طبقة سفلية مائعة
UA107711C2 (en) Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
PH12014500207B1 (en) Biocontrol of nematodes
GB201217262D0 (en) Polymers of 8,9-Dihydrobenzo(DEF)Cabazole and their use as organic semiconductors
PH12014502243A1 (en) Novel bacillus subtilis
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
WO2012089625A3 (de) Drucksensor mit kompressiblem element
NZ612294A (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
PH12015500091B1 (en) Non-pathogenic f18 e.coli strain and use thereof
EP2582851B8 (en) New strain of lactobacillus plantarum s, the use of the strain of lactobacillus plantarum s and the preparation for roughages ensiling
WO2014066903A8 (en) Biocontrol of nematodes
NZ602202A (en) Treatment of plants against oomycete infection
PH12015500066A1 (en) Shampoo composition
MX2011005281A (es) Vacuna marcadora de salmonella.
MX2022003589A (es) Lactobacillus reuteri.
WO2014170916A3 (en) Uricase mutants
NZ705406A (en) Use of attenuated strains of toxoplasma for the prevention or treatment of cryptosporidiosis

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 19 MAY 2017 BY CPA GLOBAL

Effective date: 20140710

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2018 BY GRIFFITH HACK

Effective date: 20170420

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2019 BY GRIFFITH HACK

Effective date: 20180226

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2020 BY GH MELB PAT

Effective date: 20190516

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2021 BY GH MELB DES

Effective date: 20200414

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2022 BY GRIFFITH HACK

Effective date: 20210517

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2023 BY GRIFFITH HACK

Effective date: 20220421

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2024 BY GRIFFITH HACK

Effective date: 20230419

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2025 BY GRIFFITH HACK

Effective date: 20240423

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 MAY 2026 BY GRIFFITH HACK

Effective date: 20250423